Tell HN: An inside view of Montana's new biotech law
Montana's SB535 lets sponsors of Phase 1 IND drugs treat patients for payment under state-registered ETRB oversight, reshaping trial economics.
5
Montana's SB535 lets sponsors of Phase 1 IND drugs treat patients for payment under state-registered ETRB oversight, reshaping trial economics.
Entities are extracted by the model from each article. First seen , last mentioned . Watching keeps it in this browser only (no account); the watchlist page and dashboard alerts use it.
Today 1.6K readers · 2.5K views · 780 reads · all time 189K views